{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:55:37Z","timestamp":1789419337263,"version":"build-2803163510"},"reference-count":27,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2020,3,28]]},"DOI":"10.1536\/ihj.19-420","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T22:03:47Z","timestamp":1583273027000},"page":"384-389","source":"Crossref","is-referenced-by-count":21,"title":["Successful Combination of Landiolol and Levosimendan in Patients with Decompensated Heart Failure"],"prefix":"10.1536","volume":"61","author":[{"given":"Wojciech","family":"Dabrowski","sequence":"first","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care Medical University of Lublin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Siwicka-Gieroba","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care Medical University of Lublin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Piasek","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care Medical University of Lublin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd T","family":"Schlegel","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institute"},{"name":"Nicollier-Schlegel SARL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Jaroszynski","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Institute of Medical Science, Jan Kochanowski University of Kielce"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","unstructured":"1. Zhirov I, Safronova N, Osmolovskaya Y, Alshevskaya A, Moskalev A, Tereshchenko S. Predictors of unfavourable outcomes in patients with atrial fibrillation and concomitant heart failure with different ejection fractions: RIF-CHF register one-year follow-up. Cardiol Res Pract 2019; 15: 1692104."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Li SJ, Sartipy U, Lund LH, <i>et al<\/i>. Prognostic significance of resting heart rate and use of \u03b2-blockers in atrial fibrillation and sinus rhythm in patients with heart failure and reduced ejection fraction: findings from the Swedish Heart Failure Registry. Circ Heart Fail 2015; 8: 871-9.","DOI":"10.1161\/CIRCHEARTFAILURE.115.002285"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Cha YM, Redfield MM, Shen WK, Gersh BJ. Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle. Circulation 2004; 109: 2839-43.","DOI":"10.1161\/01.CIR.0000132470.78896.A8"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. DiMarco JP. Atrial fibrillation and acute decompensated heart failure. Circ Heart Fail 2009; 2: 72-3.","DOI":"10.1161\/CIRCHEARTFAILURE.108.830349"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Cadrin-Tourigny J, Shohoudi A, Roy D, <i>et al<\/i>. Decreased mortality with beta-blockers in patients with heart failure and coexisting atrial fibrillation. JACC Heart Fail 2017; 5: 99-106.","DOI":"10.1016\/j.jchf.2016.10.015"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Pathak A, Lebrin M, Vaccaro A, Senard JM, Despas F. Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects. J Clin Pharm Ther 2013; 38: 341-9.","DOI":"10.1111\/jcpt.12067"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hein M, Roehl AB, Baumert JH, Scherer K, Steendijk P, Rossaint R. Anti-ischemic effect of inotropic agents in experimental right ventricular infarction. Acta Anaesthesiol Scand 2009; 53: 941-8.","DOI":"10.1111\/j.1399-6576.2009.01994.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Swedberg K, Cleland J, Dargie H, <i>et al<\/i>. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 1115-40.","DOI":"10.1093\/eurheartj\/ehi204"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Packer M, Colucci W, Fisher L, <i>et al<\/i>. Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure. JACC Heart Fail 2013; 1: 103-11.","DOI":"10.1016\/j.jchf.2012.12.004"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Shang G, Yang X, Song D, <i>et al<\/i>. Effects of levosimendan on patients with heart failure complicating acute coronary syndrome: a meta-analysis of randomized controlled trials. Am J Cardiovasc Drugs 2017; 17: 453-63.","DOI":"10.1007\/s40256-017-0237-0"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Frommeyer G, Kohnke A, Ellermann C, <i>et al<\/i>. Experimental evidence for a severe proarrhythmic potential of levosimendan. Int J Cardiol 2017; 228: 583-7.","DOI":"10.1016\/j.ijcard.2016.11.251"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Toivonen L, Viitasalo M, Sundberg S, Akkila J, Lehtonen L. Electrophysiologic effects of calcium sensitizer inotrope levosimendan administered intravenously in patients with normal cardiac function. J Cardiovasc Pharmacol 2000; 35: 664-9.","DOI":"10.1097\/00005344-200004000-00021"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Alhashemi JA. Treatment of cardiogenic shock with levosimendan in combination with beta-adrenergic antagonists. Br J Anaesth 2005; 95: 648-50.","DOI":"10.1093\/bja\/aei225"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Guarracino F, Landoni G, Baldassarri R, Nobile L, Stefani M. Concomitant levosimendan and esmolol infusion in ischaemic cardiogenic shock. Br J Anaesth 2010; 104: 388-9.","DOI":"10.1093\/bja\/aeq013"},{"key":"15","unstructured":"15. Matsui Y, Suzuki A, Shiga T, Arai K, Hagiwara N. Effects of intravenous landiolol on heart rate and outcomes in patients with arterial tachyarrhythmias and acute decompensated heart failure: a single-center experience. Drugs 2019; 6: 19-26."},{"key":"16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000355312","volume":"127","year":"2014","unstructured":"16. Kobayashi S, Murakami W, Myoren T, <i>et al<\/i>. A low-dose \u03b2<sub>1<\/sub>-blocker effectively and safely slows the heart rate in patients with acute decompensated heart failure and rapid atrial fibrillation. Cardiology 2014; 127: 105-13.","journal-title":"Cardiology","ISSN":"https:\/\/id.crossref.org\/issn\/0008-6312","issn-type":"print"},{"key":"17","unstructured":"17. Wajima Z, Shiga T, Imanaga K, Inoue T. Does intravenous landiolol, a \u03b2<sub>1<\/sub>-adrenergic blocker, affect stroke volume variation? J Anesth 2013; 27: 890-4."},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Kurita T, Kawashima S, Morita K, Nakajima Y. Use of a short-acting \u03b2<sub>1<\/sub> blocker during endotoxemia may reduce cerebral tissue oxygenation if hemodynamics are depressed by a decrease in heart rate. Shock 2017; 47: 765-71.","DOI":"10.1097\/SHK.0000000000000795"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Dabrowski W, Jaroszynski A, Jaroszynska A, Rzecki Z, Schlegel TT, Malbrain ML. Intra-abdominal hypertension increases spatial QRS-T angle and elevates ST-segment J-point in healthy women undergoing laparoscopic surgery. J Electrocardiol 2017; 50: 214-22.","DOI":"10.1016\/j.jelectrocard.2016.10.002"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Rhodes A, Evans LE, Alhazzani W, <i>et al<\/i>. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 2017; 43: 304-77.","DOI":"10.1007\/s00134-017-4683-6"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Selby DE, Palmer BM, LeWinter MM, Meyer M. Tachycardia-induced diastolic dysfunction and resting tone in myocardium from patients with a normal ejection fraction. J Am Coll Cardiol 2011; 58: 147-54.","DOI":"10.1016\/j.jacc.2010.10.069"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Eisner D. Calcium in the heart: from physiology to disease. Exp Physiol 2014; 99: 1273-82.","DOI":"10.1113\/expphysiol.2013.077305"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Voulgari C, Pagoni S, Tesfaye S, Tentolouris N. The spatial QRS-T angle: implications in clinical practice. Curr Cardiol Rev 2013; 9: 197-210.","DOI":"10.2174\/1573403X113099990031"},{"key":"24","unstructured":"24. Gialafos E, Konstantopoulou P, Voulgari C, <i>et al<\/i>. Abnormal spatial QRS-T angle, a marker of ventricular repolarisation, predicts serious ventricular arrhythmia in systemic sclerosis. Clin Exp Rheumatol 2012; 30: 327-31."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Steinberg C. Diagnosis and clinical management of long-QT syndrome. Curr Opin Cardiol 2018; 33: 31-41.","DOI":"10.1097\/HCO.0000000000000465"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Cetin M, U\u00e7ar O, Cicek\u00e7io\u011flu H, <i>et al<\/i>. The predictive value of QRS duration in response to levosimendan therapy in patients with decompensated heart failure. Acta Cardiol 2012; 67: 317-23.","DOI":"10.1080\/AC.67.3.2160721"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kaneko M, Yamaguchi S, Hamaguchi S, <i>et al<\/i>. Effects of landiolol on QT interval and QT dispersion during induction of anesthesia using computerized measurement. J Clin Anesth 2009; 21: 555-61.","DOI":"10.1016\/j.jclinane.2008.12.027"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/2\/61_19-420\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T03:46:40Z","timestamp":1585367200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/2\/61_19-420\/_article"}},"subtitle":["A Report of 3 Cases"],"short-title":[],"issued":{"date-parts":[[2020,3,28]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.19-420","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,28]]}}}